Vinson & Elkins Secures Major U.S. Jurisdictional Victory for Chinese Parent

On January 8, 2026, Vinson & Elkins LLP secured a decisive jurisdictional victory for Wanhua Chemical Group Co., Ltd. (“Wanhua China”) in the long-running In re Diisocyanates Antitrust Litigation, a multidistrict litigation pending before the U.S. District Court for the Western District of Pennsylvania. In a detailed 43-page opinion just released publicly, U.S. District Judge W. Scott Hardy granted with prejudice Wanhua China’s Renewed Motion to Dismiss under Federal Rule of Civil Procedure 12(b)(2), dismissing all claims against the China-based parent company for lack of personal jurisdiction.

This ruling represents one of the most significant recent decisions addressing when U.S. courts may—and may not—exercise jurisdiction over a Chinese parent company. It provides timely and practical guidance for Chinese companies with U.S. presence and operations facing growing exposure to American antitrust, class action, and commercial litigation.

A High-Stakes Antitrust MDL with Global Implications: Can a U.S. Court Assert Jurisdiction Over a Chinese Parent?

The Diisocyanates MDL, filed in 2018, consolidates numerous putative antitrust class actions alleging that chemical manufacturers conspired to fix prices and restrict the supply of methylene diphenyl diisocyanate (MDI) and toluene diisocyanate (TDI)—industrial chemicals widely used in the production of polyurethanes for construction, automotive, furniture, and consumer goods.

Plaintiffs asserted sweeping conspiracy allegations against both U.S. and non-U.S. defendants, including Wanhua China, a global chemical manufacturer headquartered in the People’s Republic of China. Although Wanhua has no presence in the United States—it does not manufacture or sell MDI or TDI here and has never been a party to any U.S. litigation—plaintiffs nevertheless attempted to hale Wanhua China into a U.S. court by arguing that the alleged conduct of its U.S. subsidiary, Wanhua Chemical (America) Co., Ltd. (“WCA”), should be imputed to its foreign parent for jurisdictional purposes. WCA is a fully capitalized, Nevada-incorporated entity with an independent, well-functioning board of directors and management team. Plaintiffs’ theory reflects an increasingly common tactic aimed at multinational companies operating in the United States through separate domestic affiliates.

Under U.S. law, personal jurisdiction over a foreign defendant requires a showing that the defendant has sufficient contacts with the United States—either contacts so continuous and systematic as to render it “at home” (general jurisdiction), or contacts reflecting that the defendant purposefully directed its conduct at the United States and that the claims arise out of or relate to that conduct (specific jurisdiction).

Plaintiffs did not (and could not) meaningfully rely on general jurisdiction. Instead, they attempted to satisfy the requirements for specific jurisdiction by advancing three primary theories:

1. “Effects” Test—asserting that Wanhua China expressly aimed anticompetitive conduct at the United States;
2. Alter-Ego Theory—arguing that WCA was so dominated and controlled by Wanhua China that corporate separateness should be disregarded; and
3. Agency Theory—contending that WCA acted as Wanhua China’s agent in the United States with respect to the alleged anticompetitive conduct.

The Court’s Decision: Corporate Separateness Matters

Judge Hardy rejected each of plaintiffs’ jurisdictional theories in their entirety as to Wanhua China. After reviewing an extensive factual record developed through jurisdictional discovery, the Court concluded that Wanhua China does not belong in the U.S. case.

With respect to general jurisdiction, the Court found no basis to deem Wanhua China “at home” in the United States. With respect to specific jurisdiction, the Court held that plaintiffs failed to establish (i) “express aiming” at the United States, or (ii) any basis for imputing WCA’s contacts to the parent under alter-ego, agency, or conspiracy theories. The Court emphasized the absence of evidence showing the type of day-to-day control necessary to disregard corporate separateness.

Key findings from the Court’s opinion include:

• No U.S. sales or manufacturing by the parent. The Court emphasized that Wanhua China does not manufacture or sell MDI or TDI in the United States, undermining any claim that it purposefully directed relevant conduct at the U.S. market. 
• Ordinary parent–subsidiary relationships are not enough. Wholly owned status, overlapping officers, shared branding, and strategic coordination did not justify disregarding corporate boundaries. The Court found that Wanhua China and WCA maintained separate finances, operations, and decision-making, reflecting a conventional parent–subsidiary relationship rather than undue domination.
• No agency for jurisdictional purposes. Plaintiffs failed to show that WCA acted on Wanhua China’s behalf in a manner that would permit imputation of jurisdictional contacts. Even close parent–subsidiary relationships do not, standing alone, establish agency.

In short, the Court reaffirmed a fundamental principle of U.S. jurisdictional law: a foreign parent company does not automatically submit itself to U.S. jurisdiction merely by owning a U.S. subsidiary—even where that subsidiary remains a defendant in the case.

A Rare and Hard-Fought Discovery Record Involving China

The outcome is particularly notable given the procedural history of the case. In March 2020, the Court denied the initial jurisdictional motions without prejudice and ordered limited jurisdictional discovery, reflecting the seriousness with which U.S. courts treat jurisdictional challenges in complex MDLs. Nearly three years of “limited” jurisdictional discovery ensued, and Wanhua China responded to dozens of Plaintiffs’ discovery requests, produced thousands of documents, and litigated multiple discovery motions.

Critically, this discovery unfolded against the backdrop of China’s then-newly enacted Data Security Law (DSL) and Personal Information Protection Law (PIPL) that restrict the transfer of certain data outside China without government approval. Despite these constraints, Vinson & Elkins successfully worked with Wanhua China and Chinese counsel to obtain Chinese government approval to produce documents for use in U.S. litigation. This remains an exceptionally rare example—and possibly the first—of securing such approval under China’s modern data-protection regime.

The resulting factual record ultimately proved decisive. Rather than undermining Wanhua China’s defenses, jurisdictional discovery confirmed the independence of the parent company from U.S. commercial activity, enabling the Court to rule decisively in Wanhua China’s favor.

Practical Takeaways for Chinese Parent Companies

This ruling carries important implications for foreign parent companies operating globally, particularly those with U.S. subsidiaries. Chinese companies with U.S. exposure should consider the following steps:

• Engage coordinated U.S. and China-law expertise at the outset of any cross-border dispute.
• Evaluate jurisdictional risk early when U.S. litigation arises.
• Assess parent-subsidiary relationships through the lens of U.S. jurisdictional doctrines.
• Prepare for potential jurisdictional discovery, including data-governance planning under Chinese law.

Vinson & Elkins has extensive experience representing Chinese and multinational companies in complex U.S. litigation, including antitrust MDLs, class actions, and jurisdictional disputes. The successful dismissal of Wanhua China reflects the firm’s ability to integrate U.S. litigation strategy, cross-border discovery execution, and Chinese regulatory compliance in matters involving the highest stakes.